Global Medical Implant Market Research Report—Forecast till 2027

$4,450$6,250

Global Medical Implant Market is anticipated to exhibit a CAGR of 7.60% during the review period of 2020 to 2027, to surpass USD 279,418.06 Million by 2027. Medical implants are tissues or instruments placed on the body surface for various reasons.

Clear

Description

Global Medical Implant Market Research Report—Forecast till 2027

Market Dynamics
Global Medical Implant Market is anticipated to exhibit a CAGR of 7.60% during the review period of 2020 to 2027, to surpass USD 279,418.06 Million by 2027. Medical implants are tissues or instruments placed on the body surface for various reasons. The major applications of medical implants are to monitor body functions, give support to body parts and tissues. These implants are made up of different types of body parts such as skin, bone, or other body tissues and various artificial elements such as metal, plastic, ceramic or other materials. The medical implants can be placed permanently, or they can be removed once they are no longer needed.
The global medical implant market is estimated to register notable market growth during the review period during the forecast period. The global market expansion is attributed to the focus of major market players to provide the best treatments with economic prices and advanced technology. The success rate of these products is one of the major factors, which boosts the demand for medical implants during the review period.
Market Segmentation
Global Medical Implant Market has been classified into Type, Type of Material, and End User.
Based on type segment, the global medical implant market has been classified into orthopedic implants, cardiac implants, spinal implants, dental implants, ophthalmic implants, cosmetic implants, others. In terms of the type of material segment, the global medical implant market has been segmented divided into metallic material, ceramic material, polymers material, others.
Based on End User type the market has been segmented into Hospitals & Clinics, Research Laboratories, and Others.
Regional Analysis
Geographically, the Global Medical Implant Market, based has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to drive the global market owing to the highest market in the US and Canada. The regional market growth is driven by the high prevalence of chronic diseases, product launches, and technological advancement.
The European medical implant market has been segmented into Western Europe and Eastern Europe. The Western Europe medical implant market has further been divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Furthermore, an increase in the number of patients undergoing knee and hip replacement surgeries is expected to propel the regional market growth.
The medical implant market in Asia-Pacific has been spread across China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is anticipated to register the highest market growth potential over the forecast period owing to the population of age 65 and above is estimated to grow dramatically over the next 50 years. Additionally, the rising per capita disposable income of middle-class families results in individuals spending more on health is likely to set the market growth in the region.
Major Players
The Key Players in the Global Medical Implant Market include Boston Scientific Corporation (US), Johnson & Johnson (US), Stryker Corporation (US), 3M (US), and Zimmer Biomet (US).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 16

2.2 RESEARCH OBJECTIVE 16

2.3 LIST OF ASSUMPTIONS & LIMITATIONS 17

3 RESEARCH METHODOLOGY
3.1 OVERVIEW 19

3.2 DATA MINING 19

3.3 SECONDARY RESEARCH 20

3.4 PRIMARY RESEARCH 21

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 22

3.5 FORECASTING TECHNIQUES 23

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24

3.6.1 BOTTOM-UP APPROACH 24

3.6.2 TOP-DOWN APPROACH 25

3.7 DATA TRIANGULATION 26

3.8 VALIDATION 26

4 MARKET DYNAMICS
4.1 OVERVIEW 27

4.2 DRIVERS 28

4.2.1 IMPROVEMENT IN SURGICAL OUTCOMES 28

4.2.2 INCREASING PREVALENCE OF CHRONIC DISEASES 28

4.2.3 GROWING GERIATRIC POPULATION 29

4.3 RESTRAINTS 30

4.3.1 AMBIGUOUS REGULATORY FRAMEWORK 30

4.3.2 RISK OF INFECTIONS DUE TO MEDICAL IMPLANTS 30

4.4 OPPORTUNITY 31

4.4.1 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL IMPLANTS 31

5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 33

5.1.1 R&D AND DESIGNING 34

5.1.2 MANUFACTURING 34

5.1.3 DISTRIBUTION 34

5.1.4 MARKETING & SALES 34

5.2 PORTER’S FIVE FORCES MODEL 35

5.2.1 THREAT OF NEW ENTRANTS 36

5.2.2 BARGAINING POWER OF SUPPLIERS 36

5.2.3 THREAT OF SUBSTITUTES 36

5.2.4 BARGAINING POWER OF BUYERS 36

5.2.5 INTENSITY OF RIVALRY 36

5.3 IMPACT OF COVID-19 37

5.3.1 IMPACT ON DEMAND 37

5.3.2 IMPACT ON SUPPLY 37

5.3.3 IMPACT ON MARKET PLAYER 37

6 GLOBAL MEDICAL IMPLANTS MARKET, BY TYPE
6.1 OVERVIEW 38

6.2 ORTHOPEDIC IMPLANTS 39

6.3 CARDIAC IMPLANTS 40

6.4 SPINAL IMPLANTS 41

6.5 DENTAL IMPLANTS 42

6.6 OPHTHALMIC IMPLANTS 43

6.7 COSMETIC IMPLANTS 44

6.8 OTHERS 45

7 GLOBAL MEDICAL IMPLANTS MARKET, BY TYPE OF MATERIAL
7.1 OVERVIEW 46

7.2 METALLIC MATERIAL 47

7.3 CERAMIC MATERIAL 47

7.4 POLYMERS MATERIAL 48

7.5 OTHERS 49

8 GLOBAL MEDICAL IMPLANTSMARKET, BY END USER
8.1 OVERVIEW 50

8.2 HOSPITALS & CLINICS 51

8.3 SPECIALTY CENTRES 51

8.4 OTHERS 52

9 GLOBAL MEDICAL IMPLANTS MARKET, BY REGION
9.1 OVERVIEW 53

9.2 AMERICAS 54

9.2.1 NORTH AMERICA 57

9.2.1.1 US 60

9.2.1.2 CANADA 62

9.2.2 LATIN AMERICA 64

9.3 EUROPE 67

9.3.1 WESTERN EUROPE 70

9.3.1.1 GERMANY 73

9.3.1.2 FRANCE 75

9.3.1.3 UK 77

9.3.1.4 ITALY 79

9.3.1.5 SPAIN 81

9.3.1.6 REST OF WESTERN OF EUROPE 83

9.3.2 EASTERN EUROPE 85

9.4 ASIA-PACIFIC 88

9.4.1 JAPAN 91

9.4.2 CHINA 93

9.4.3 INDIA 95

9.4.4 AUSTRALIA 97

9.4.5 SOUTH KOREA 99

9.4.6 REST OF ASIA-PACIFIC 101

9.5 MIDDLE EAST & AFRICA 104

9.5.1 MIDDLE EAST 107

9.5.2 AFRICA 109

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 112

10.2 GLOBAL MEDICAL IMPLANTS MARKET SHARE ANALYSIS (2019) 112

10.3 COMPETITIVE BENCHMARKING 113

10.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL MEDICAL IMPLANTS MARKET 114

10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MEDICAL IMPLANTS MARKET 114

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 115

10.6.1 EXPANSION 115

10.6.2 PRODUCT APPROVAL/FDA APPROVAL 116

11 COMPANY PROFILES
11.1 BOSTON SCIENTIFIC CORPORATION 117

11.1.1 COMPANY OVERVIEW 117

11.1.2 FINANCIAL OVERVIEW 117

11.1.3 PRODUCTS/SERVICES OFFERED 118

11.1.4 KEY DEVELOPMENTS 119

11.1.5 SWOT ANALYSIS 120

11.1.6 KEY STRATEGIES 120

11.2 MEDTRONIC PLC 121

11.2.1 COMPANY OVERVIEW 121

11.2.2 FINANCIAL OVERVIEW 121

11.2.3 PRODUCTS/SERVICES OFFERED 122

11.2.4 KEY DEVELOPMENTS 124

11.2.5 SWOT ANALYSIS 125

11.2.6 KEY STRATEGIES 125

11.3 JOHNSON & JOHNSON SERVICES, INC. 126

11.3.1 COMPANY OVERVIEW 126

11.3.2 FINANCIAL OVERVIEW 126

11.3.3 PRODUCTS/SERVICES OFFERED 127

11.3.4 KEY DEVELOPMENTS 127

11.3.5 SWOT ANALYSIS 128

11.3.6 KEY STRATEGIES 128

11.4 3M 129

11.4.1 COMPANY OVERVIEW 129

11.4.2 FINANCIAL OVERVIEW 129

11.4.3 PRODUCTS/SERVICES OFFERED 130

11.4.4 KEY DEVELOPMENTS 130

11.4.5 SWOT ANALYSIS 131

11.4.6 KEY STRATEGIES 131

11.5 INSTITUT STRAUMANN AG 132

11.5.1 COMPANY OVERVIEW 132

11.5.2 FINANCIAL OVERVIEW 132

11.5.3 PRODUCTS/SERVICES OFFERED 133

11.5.4 KEY DEVELOPMENTS 134

11.5.5 SWOT ANALYSIS 135

11.5.6 KEY STRATEGIES 135

11.6 STRYKER 136

11.6.1 COMPANY OVERVIEW 136

11.6.2 FINANCIAL OVERVIEW 136

11.6.3 PRODUCTS/SERVICES OFFERED 137

11.6.4 KEY DEVELOPMENTS 137

11.6.5 SWOT ANALYSIS 138

11.6.6 KEY STRATEGIES 138

11.7 ZIMMER BIOMET HOLDINGS INC. 139

11.7.1 COMPANY OVERVIEWS 139

11.7.2 FINANCIAL OVERVIEW 139

11.7.3 PRODUCTS/SERVICES OFFERED 140

11.7.4 KEY DEVELOPMENTS 140

11.7.5 SWOT ANALYSIS 141

11.7.6 KEY STRATEGIES 141

11.8 SMITH & NEPHEW 142

11.8.1 COMPANY OVERVIEW 142

11.8.2 FINANCIAL OVERVIEW 142

11.8.3 PRODUCTS/SERVICES OFFERED 143

11.8.4 KEY DEVELOPMENTS 143

11.8.5 SWOT ANALYSIS 144

11.8.6 KEY STRATEGIES 144

11.9 DENTSPLY SIRONA 145

11.9.1 COMPANY OVERVIEW 145

11.9.2 FINANCIAL OVERVIEW 145

11.9.3 PRODUCTS/SERVICES OFFERED 146

11.9.4 KEY DEVELOPMENTS 146

11.9.5 SWOT ANALYSIS 147

11.9.6 KEY STRATEGIES 147

11.10 B. BRAUN MELSUNGEN AG 148

11.10.1 COMPANY OVERVIEW 148

11.10.2 FINANCIAL OVERVIEW 148

11.10.3 PRODUCTS/SERVICES OFFERED 149

11.10.4 KEY DEVELOPMENTS 149

11.10.5 SWOT ANALYSIS 150

11.10.6 KEY STRATEGIES 150

12 APPENDIX
12.1 REFERENCES 151

12.2 RELATED REPORTS 151